Neogen Corporation operates in the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Neogen with three other
pharmaceutical manufacturers in North America:
Natural Alternatives International, Inc.
sales of $114.20 million
of which 81%
was Private Label Contract Manufacturing),
Array BioPharma Inc.
of which 100%
was Small Molecular Drugs), and
of which 64%
Neogen reported sales of $321.28 million
May of 2016.
increase of 13.5%
versus 2015, when the company's sales were $283.07 million.
Sales at Neogen have increased during each of the previous five years
(and since 2011, sales have increased a total of 86%).
Sales of Animal Safety saw an increase
15.7% in 2016, from
$151.60 million to $175.43 million.